139 related articles for article (PubMed ID: 1659431)
1. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
Krah DL
Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
[TBL] [Abstract][Full Text] [Related]
2. A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus.
Krah DL; Amin RD; Nalin DR; Provost PJ
J Infect Dis; 1991 Mar; 163(3):634-7. PubMed ID: 1847404
[TBL] [Abstract][Full Text] [Related]
3. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
Beales LP; Wood DJ; Minor PD; Saldanha JA
J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
[TBL] [Abstract][Full Text] [Related]
4. Isolation and adaptation characteristics of hepatitis A virus in primary African green monkey kidney cells: production of antigen useful for ELISA serology.
Wang KQ; Nielsen CM; Vestergaard BF
Intervirology; 1985; 24(2):99-107. PubMed ID: 2997078
[TBL] [Abstract][Full Text] [Related]
5. The heat sensitivity of hepatitis A virus determined by a simple tissue culture method.
Parry JV; Mortimer PP
J Med Virol; 1984; 14(3):277-83. PubMed ID: 6094725
[TBL] [Abstract][Full Text] [Related]
6. An inactivated hepatitis A viral vaccine of cell culture origin.
Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
[TBL] [Abstract][Full Text] [Related]
7. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.
Crance JM; Passagot J; Biziagos E; Deloince R
J Virol Methods; 1987 Nov; 18(2-3):193-203. PubMed ID: 2828401
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity of hepatitis A virus after ultra-violet inactivation.
Wang CH; Tschen SY; Flehmig B
Vaccine; 1995 Jun; 13(9):835-40. PubMed ID: 7483806
[TBL] [Abstract][Full Text] [Related]
9. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
Yap KL; Lam SK
J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
[TBL] [Abstract][Full Text] [Related]
11. In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203).
Villar LM; Amado LA; Gaspar AM
Braz J Med Biol Res; 2004 Jul; 37(7):1023-7. PubMed ID: 15264009
[TBL] [Abstract][Full Text] [Related]
12. A "reverse" solid-phase radio-immuno-assay for IgM-antibodies to hepatitis A virus.
Meurman OH; Matter L; Krishna RV; Krech UH
Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):79-84. PubMed ID: 6270954
[TBL] [Abstract][Full Text] [Related]
13. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
Chitambar SD; Arankalle VA; Banerjee K
Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
[TBL] [Abstract][Full Text] [Related]
14. A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations.
Konduru K; Virata-Theimer ML; Yu MY; Kaplan GG
Virol J; 2008 Dec; 5():155. PubMed ID: 19094229
[TBL] [Abstract][Full Text] [Related]
15. Isolation and propagation of hepatitis A virus in hepatoma cell cultures.
Friedman-Alvermann B; Müller D; Spies K
Acta Virol; 1985 Dec; 29(6):482-6. PubMed ID: 2869659
[TBL] [Abstract][Full Text] [Related]
16. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
[TBL] [Abstract][Full Text] [Related]
17. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.
Anderson DA
J Med Virol; 1987 May; 22(1):35-44. PubMed ID: 3035078
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated vaccine for hepatitis A.
Feinstone SM; Daemer RJ; Gust ID; Purcell RH
Dev Biol Stand; 1983; 54():429-32. PubMed ID: 6317493
[TBL] [Abstract][Full Text] [Related]
19. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
Hughes JV; Stanton LW
J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a hepatitis A virus vaccine.
Flehmig B; Haage A; Pfisterer M
J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
